Cat. No. |
Product Name |
Information |
PC-73280 |
Quinabactin
ABA agonist
|
Quinabactin is a small molecule abscisic acid (ABA) receptor agonist that preferentially activates dimeric ABA receptors and possesses ABA-like potency in vivo. |
PC-73279 |
Opabactin
ABA agonist
|
Opabactin is an abscisic acid (ABA) mimic and ABA receptor agonist Arabidopsis subfamily III/II ABA receptors with nanomolar potency (7 nM). |
PC-73278 |
Antabactin
ABA antagonist
|
Antabactin (ANT) is a highly potent pan-abscisic acid (ABA) receptor antagonist with EC50 of 760 nM and picomolar dissociation constant, disrupts signaling by preventing receptor-PP2C interactions. |
PC-73272 |
Heparanase-IN-2
Heparanase inhibitor
|
Heparanase-IN-2 is a potent, small molecule Heparanase (Hpse) inhibitor with IC50 of 0.12 uM. |
PC-73271 |
Heparanase-IN-1
Heparanase inhibitor
|
Heparanase-IN-1 is a small molecule Heparanase (Hpse) inhibitor with IC50 of 0.56 uM. |
PC-73270 |
SST0872AA1
Heparanase inhibitor
|
SST0872AA1 is a potent, small molecule Heparanase (Hpse) inhibitor with IC50 of 0.08 uM. |
PC-73269 |
SST0871AA1
Heparanase inhibitor
|
SST0871AA1 is a small molecule Heparanase (Hpse) inhibitor with IC50 of 0.64 uM. |
PC-73217 |
Ceapin-A7
ATF6 inhibitor
|
Ceapin-A7 is a selective inhibitor of ATF6α with IC50 of 0.59 uM, selective over ATF6β, PERK and other branches of the unfolded protein response (UPR). |
PC-73185 |
Hi 76-0079
HSL inhibitor
|
Hi 76-0079 (NNC0076-0079) is a specfic, small molecule inhibitor of hormone-sensitive lipase (HSL) with IC50 of 0.11 uM. |
PC-73175 |
SGN-2FF
Fucosylation inhibitor
|
SGN-2FF is a potent and orally active inhibitor of glycoprotein fucosylation, directly inhibits fucosyltransferase activity. |
PC-73159 |
JHU37160
DREADD agonist
|
JHU37160 is a high affinity, highly potent, BBB penetrant activator (agonist) of hM3Dq and hM4Di DREADDs with Ki 1.9 nM and 3.6 nM for hM3Dq and hM4Di in vitro. |
PC-73151 |
Eptifibatide
Glycoprotein IIb/IIIa inhibitor
|
Eptifibatide (Integrilin) is a synthetic homodetic cyclic peptide, inhibits platelet aggregation by selectively blocking the platelet glycoprotein IIb/IIIa receptor. |